Such differences might be correlated to distinct cell of origins, giving rise to cancer stem cells featuring the distinct iCCA subtypes that are, in turn, responsible for the generation of EMT with diverse properties, and with a differential responsiveness to drugs2,3,11,13. The gene discussed is PRRT2; the disease is cancer.